Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02171 CARSGEN-B > Detailed Quotes

02171 CARSGEN-B

11.6200.0000.00%
Pre-Market Auction Session 10/06 09:00 CCT
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
11.620
Volume
0.00
Market Cap
6.63B
P/E(TTM)
Loss
52wk High
49.700
Shares
570.61M
P/E(Static)
Loss
52wk Low
9.680
Float Cap
6.63B
Bid/Ask %
42.86%
Historical High
57.250
Shs Float
570.61M
Volume Ratio
0.00
Historical Low
9.680
Dividend TTM
--
Div Yield TTM
--
P/B
2.03
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
500
Float Cap
6.63B
Bid/Ask %
42.86%
Historical High
57.250
Shs Float
570.61M
Volume Ratio
0.00
Historical Low
9.680
Dividend TTM
--
P/B
2.03
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Keji Pharmaceutical Holdings Co., Ltd. is a Chinese investment holding company mainly engaged in the discovery, development and sales of innovative chimeric antigen receptor (CAR) T cell therapy. The company's treatments are used to treat hematological malignancies and solid tumors. The company has developed an upgraded version of CAR-T product CT053, which targets B cell mature antigen (BCMA). CT053 is its only core candidate. The company operates in China and the United States.
CEO: Zonghai Li
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...